Session I: Diabetes Management

6:30 - 7:45 am

CME Breakfast Symposium

The Role of CGM in Individualization of T2DM Management

Chair: Anne L. Peters, MD

Presenter: Irl B. Hirsch, MD

Supported by educational grants from Dexcom, Inc. and Medtronic.

7:55 - 8:00 am

Opening Remarks

Jay S. Skyler, MD

8:00 - 9:30 am

FDA Update and Late Breaking Clinical Trials

Chair: Christie M. Ballantyne, MD

Panelists: Robert H. Eckel, MD; Jay S. Skyler, MD; Keith C. Ferdinand, MD; Deepak L. Bhatt, MD, MPH

9:30 - 10:15 am

10:15 - 11:15 am

Morning Break - Exhibit Hall

11:15 am - 12:00 pm

So Many Options - Dispelling the Confusion About Insulins

Irl B. Hirsch, MD

This session is supported by an educational grant from Novo Nordisk.

12:10 - 1:25 pm

CME Lunch Symposium A
Management of T2DM Patients with Diabetic Kidney Disease: Effects of SGLT2 Inhibitors and GLP1 Receptor Agonists on Disease Progression

Chair: Matt Weir, MD

Presenters: Lance Sloan, MD; Robert D. Toto, MD

Supported by educational grants from Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC. and by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC

12:10 - 1:25 pm

CME Lunch Symposium B
Advances in HFpEF: Addressing Diagnostic and Treatment Challenges

Chair: JoAnn Lindenfeld, MD

Presenters: Keith C. Ferdinand, MD; Alanna A. Morris, MD

Supported by an educational grant from Novartis Pharmaceuticals Corporation.

1:35 - 2:20 pm

Where Are We with Devices for Diabetes Management?

Anne L. Peters, MD

2:20 - 3:20 pm

Afternoon Break - Exhibit Hall

3:20 - 3:50 pm

How Many GLP1 RAs Do We Need and Why?

John B. Buse, MD

3:50 - 5:05 pm

Multidisciplinary Case Consults

Chair: Jay S. Skyler, MD

Panelists: John B. Buse, MD; Robert H. Eckel, MD; Davida F. Kruger, MSN, APNBC, BCADM; Anne L. Peters, MD; Irl B. Hirsch, MD

5:10 - 6:10 pm

6:20 - 7:35 pm

CME Dinner Symposium

Mastering the Prior Authorization Process to Meet Patient Needs

Chair: Pamela B. Morris, MD

Presenters: Christie M. Ballantyne, MD; Kim K. Birtcher, PharmD

Supported by an educational grant from Sanofi US and Regeneron Pharmaceuticals.

7:40 - 8:40 pm

PME Dinner Symposium (Non-CME)

Sponsored by Akcea Therapeutics

Session II: Obesity and Lifestyle Management in Cardiovascular Disease

6:30 - 7:45 am

CME Breakfast Symposium

The ABC Access Program: Overcoming Barriers to Access of Newer Cardiovascular Agents for High-Risk and Minority Patients

Chair: Keith C. Ferdinand, MD

Faculty: Deirdre Mattina, MD; Catherine Davis Ahmed, MBA

Supported by an educational funding donation provided by Amgen and in partnership with the Association of Black Cardiologists, Inc (ABC).

7:55 - 8:00 am

Opening Remarks
Robert H. Eckel, MD

8:00 - 8:45 am

Heart Healthy Nutrition

Stephen Devries, MD

8:45 - 9:15 am

Updates on the Microbiome and Metabolic Surgery

Mary-Elizabeth Patti, MD

9:15 - 10:15 am

Morning Break - Exhibit Hall

10:15 - 11:00 am

Obesity and Environmental Influence: The Big Picture

James O. Hill, PhD

11:00 - 11:45 am

Day to Day Management of Obesity in Clinical Practice

Robert F. Kushner, MD

11:45 - 11:50 am

Closing Remarks
Robert H. Eckel, MD

12:00 - 1:15 pm

CME Lunch Symposium A
Identifying, Diagnosing and Managing Iron Deficiency in Patients with Heart Failure to Improve Outcomes and Quality of Life

Chair: Clyde W. Yancy, MD

Presenters: Biykem Bozkurt, MD; Gurushner Panjrath, MD

Supported by an educational grant from American Regent.

12:00 - 1:15 pm

CME Lunch Symposium B
New Developments in Type 2 Diabetes Treatment to Decrease the Risk of Hypoglycemia

Chair: Robert E. Ratner, MD

Presenters: Robert H. Eckel, MD; Davida Kruger, MSN, APN-BC, BCADM; Deborah J. Wexler, MD

Supported by an educational grant from Sanofi US.

Session III: Dyslipidemia, Atherosclerosis, and Cardiovascular Disease Risk Reduction

1:25 - 1:30 pm

Opening Remarks
Christie M. Ballantyne, MD

1:30 - 2:20 pm

Targeting Inflammation: Updates on Pathophysiology and Clinical Outcomes

Peter Libby, MD;
Paul M. Ridker, MD

This session is supported by an educational grant from Novartis Pharmaceuticals Corporation.

2:20 - 3:20 pm

Afternoon Break - Exhibit Hall

3:20 - 4:10 pm

How Aggressively Do We Lower LDL-C and for Which Patients?

Vera A. Bittner, MD, MSPH;
Marc S. Sabatine, MD, MPH

4:10 - 5:00 pm

Risk Assessment for Global Cardiovascular Disease: Imaging and Biomarkers

Matthew J. Budoff, MD;
James de Lemos, MD

5:00 - 6:00 pm

Multidisciplinary Case Consults

Chair: Christie M. Ballantyne, MD

Panelists: Robert H. Eckel, MD; Pamela B. Morris, MD; Margo B. Minissian, PhD, ACNP; Pam R. Taub, MD; Vera A. Bittner, MD, MSPH

This session is supported by educational grants from Amarin Pharma, Inc and Akcea Therapeutics.

6:00 - 6:05 pm

Closing Remarks
Christie M. Ballantyne, MD

6:05 - 7:05 pm

7:15 - 8:15 pm

PME Dinner Symposium (Non-CME)

Sponsored by Novo Nordisk

Session IV: Hypertension, Cardio-renal, and Heart Failure

6:30 - 7:45 am

CME Breakfast Symposium
Finding the Balance: Treatment and Management of Hyperkalemia in Patients with Heart Failure and Chronic Kidney Disease

Supported by an educational grant from Relypsa, Inc.

7:55 - 8:00 am

Opening Remarks
George L. Bakris, MD

8:00 - 9:00 am

Overview of the New 2017 Hypertension Clinical Practice Guidelines

George L. Bakris, MD

9:00 - 9:30 am

Comparing the Hypertension Guidelines - Where is the Equipoise?

William B. White, MD

9:30 - 9:45 am

Nutrition Break

9:45 - 10:45 am

Patient Cases: How would you change the management of hypertension based on the new guidelines?

Aldo Peixoto, MD; William B. White, MD; Keith C. Ferdinand, MD

10:45 - 11:15 am

Prevention of Heart Failure: The Next Frontier

Clyde W. Yancy, MD

11:15 - 11:25 am

Mini Break

11:25 - 11:55 am

Integration of Biomarkers and Prediction of AKI and Cardio-renal Outcomes in Clinical Practice

Aldo Peixoto, MD

11:55 am - 12:25 pm

AKI and Heart Failure: How to manage compared to general population?

Peter A. McCullough, MD

12:25 - 12:55 pm

Advanced CKD and Benefits From CVOTs

Jorge Plutzky, MD

12:55 - 1:00 pm

Closing Remarks